Home › Neurofibrosarcoma › Maryland
Neurofibrosarcoma clinical trials in Maryland
4 studies for Neurofibrosarcoma are looking for participants at sites in Maryland.
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1
Ages 12 to 120 · All sexes · Updated Sep 23, 2026 · NCT04222413Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational study
Ages 3 to 120 · All sexes · Updated Sep 2, 2026 · NCT06222203SPEARHEAD-3 Pediatric Study
- National Institutes of Health, Bethesda
RecruitingPhase 1/2
Ages 2 to 21 · All sexes · Updated Aug 11, 2026 · NCT05642455Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
- Johns Hopkins, Baltimore
- National Institutes of Health (NIH), Bethesda
RecruitingObservational study
All ages · All sexes · Updated Mar 9, 2026 · NCT03141021From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.